72 companies

Palantir Technologies

Market Cap: US$422.6b

Palantir Technologies Inc. builds and deploys software platforms for the intelligence community to assist in counterterrorism investigations and operations in the United States, the United Kingdom, and internationally.

PLTR

US$178.15

7D

0.5%

1Y

317.2%

Vanda Pharmaceuticals

Market Cap: US$311.4m

A biopharmaceutical company, focuses on the development and commercialization of therapies to address high unmet medical needs worldwide.

VNDA

US$5.27

7D

0.8%

1Y

11.4%

Workday

Market Cap: US$62.5b

Provides enterprise cloud applications in the United States and internationally.

WDAY

US$234.25

7D

-1.0%

1Y

-3.9%

Zscaler

Market Cap: US$47.5b

Operates as a cloud security company worldwide.

ZS

US$300.25

7D

-4.1%

1Y

59.7%

Aldeyra Therapeutics

Market Cap: US$315.8m

A biotechnology company, discovers and develops therapies designed to treat immune-mediated and metabolic diseases.

ALDX

US$5.26

7D

0.2%

1Y

-4.9%

ADMA Biologics

Market Cap: US$3.4b

A biopharmaceutical company, develops, manufactures, and markets specialty plasma-derived biologics for the treatment of immune deficiencies and infectious diseases in the United States and internationally.

ADMA

US$14.36

7D

-1.3%

1Y

-8.1%

Exelixis

Market Cap: US$10.6b

An oncology company, focuses on the discovery, development, and commercialization of new medicines for difficult-to-treat cancers in the United States.

EXEL

US$39.25

7D

2.1%

1Y

37.0%

Circle Internet Group

Market Cap: US$29.3b

Operates as a platform, network, and market infrastructure for stablecoin and blockchain applications.

CRCL

US$126.49

7D

-8.0%

1Y

n/a

Gorilla Technology Group

Market Cap: US$485.9m

Provides solutions in security, network, business intelligence, and Internet of Things (IoT) technology in Taiwan and the United Kingdom.

GRRR

US$16.95

7D

-9.4%

1Y

241.7%

OS Therapies

Market Cap: US$62.0m

A clinical stage biopharmaceutical company, focuses on the identification, development, and commercialization of treatments for osteosarcoma and other solid tumors in the United States.

OSTX

US$1.85

7D

-5.1%

1Y

-38.1%

RenovoRx

Market Cap: US$41.0m

A clinical-stage biopharmaceutical company, engages in the developing of targeted combination therapies to enhance therapeutic outcomes for cancer patients undergoing treatment.

RNXT

US$1.12

7D

3.7%

1Y

12.6%

HubSpot

Market Cap: US$23.0b

Provides a cloud-based customer relationship management (CRM) platform for businesses in the Americas, Europe, and the Asia Pacific.

HUBS

US$436.82

7D

-2.9%

1Y

-18.0%

Atlassian

Market Cap: US$40.0b

Provides a collaboration software that enables organizations to connect all teams through a system of work that unlocks productivity at scale worldwide.

TEAM

US$151.95

7D

1.7%

1Y

-21.2%

Kiniksa Pharmaceuticals International

Market Cap: US$2.9b

A biopharmaceutical company, developing and commercializing novel therapies for diseases with unmet need and focuses on cardiovascular indications worldwide.

KNSA

US$38.64

7D

4.3%

1Y

49.3%

Cellebrite DI

Market Cap: US$4.4b

Develops solutions for legally sanctioned investigations in Europe, the Middle East, Africa, the Americas, and the Asia-Pacific.

CLBT

US$18.18

7D

-7.1%

1Y

0.2%

Reddit

Market Cap: US$36.5b

Operates a digital community in the United States and internationally.

RDDT

US$194.95

7D

-4.3%

1Y

148.2%

Zeta Global Holdings

Market Cap: US$4.2b

Operates an omnichannel data-driven cloud platform that provides enterprises with consumer intelligence and marketing automation software in the United States and internationally.

ZETA

US$17.82

7D

-5.7%

1Y

-33.7%

Commvault Systems

Market Cap: US$7.6b

Provides a cyber resilience platform for protecting and recovering data and cloud-native applications in the Americas and internationally.

CVLT

US$171.90

7D

-2.1%

1Y

23.7%

Krystal Biotech

Market Cap: US$5.5b

A commercial-stage biotechnology company, discovers, develops, manufactures, and commercializes genetic medicines to treat diseases with high unmet medical needs in the United States.

KRYS

US$190.23

7D

3.0%

1Y

6.3%

BioRestorative Therapies

Market Cap: US$13.7m

Develops therapeutic products and medical therapies using cell and tissue protocols primarily involving adult stem cells.

BRTX

US$1.59

7D

-0.9%

1Y

-5.5%

Cheetah Mobile

Market Cap: US$224.0m

Provides internet services, artificial intelligence (AI), and other services in the People’s Republic of China, Hong Kong, Japan, and internationally.

CMCM

US$7.39

7D

-6.0%

1Y

65.0%

Anavex Life Sciences

Market Cap: US$771.3m

Operates as a biopharmaceutical company.

AVXL

US$8.98

7D

4.2%

1Y

64.8%

Protalix BioTherapeutics

Market Cap: US$148.3m

A biopharmaceutical company, engages in the development, production, and commercialization of recombinant therapeutic proteins based on the ProCellEx plant cell-based protein expression system.

PLX

US$1.86

7D

-24.1%

1Y

75.5%

Creative Medical Technology Holdings

Market Cap: US$9.3m

A commercial-stage biotechnology company, focuses on novel biological therapeutics in the fields of immunotherapy, endocrinology, urology, neurology, and orthopedics in the United States.

CELZ

US$3.59

7D

5.3%

1Y

-21.4%

Glimpse Group

Market Cap: US$31.6m

An immersive technology company provides enterprise focused virtual reality (VR), augmented reality (AR), and spatial computing software and services in the United States.

VRAR

US$1.50

7D

1.4%

1Y

115.8%

Evaxion

Market Cap: US$42.9m

A clinical-stage biotech company, develops artificial intelligence-powered immunology vaccines.

EVAX

US$6.79

7D

8.5%

1Y

-46.5%

MNTN

Market Cap: US$1.1b

Operates a technology platform that brings performance marketing to Connected TV.

MNTN

US$15.03

7D

-5.4%

1Y

n/a

Trade Desk

Market Cap: US$24.4b

Operates as a technology company in the United States and internationally.

TTD

US$49.98

7D

-2.5%

1Y

-57.7%

Gyre Therapeutics

Market Cap: US$753.9m

A pharmaceutical company, engages in the development and commercialization of small-molecule, anti-inflammatory, and anti-fibrotic drugs targeting organ fibrosis.

GYRE

US$8.30

7D

-1.1%

1Y

-41.3%

GeoVax Labs

Market Cap: US$16.4m

A clinical-stage biotechnology company, develops human vaccines and immunotherapies against infectious diseases and solid tumor cancers using novel proprietary platforms in the United States.

GOVX

US$0.55

7D

-0.6%

1Y

-75.3%

Applied Optoelectronics

Market Cap: US$2.0b

Designs, manufactures, and sells fiber-optic networking products in the United States, Taiwan, and China.

AAOI

US$31.92

7D

9.7%

1Y

72.4%

Aprea Therapeutics

Market Cap: US$9.1m

A clinical-stage biopharmaceutical company, focuses on developing and commercializing novel synthetic lethality-based cancer therapeutics that targets DNA damage response pathways.

APRE

US$1.57

7D

6.8%

1Y

-63.5%

Arcturus Therapeutics Holdings

Market Cap: US$561.0m

Engages in the development of infectious disease vaccines and other products within liver and respiratory rare diseases.

ARCT

US$20.66

7D

6.5%

1Y

-1.1%

Pure Storage

Market Cap: US$30.2b

Provides data storage and management technologies, products, and services in the United States and internationally.

PSTG

US$91.85

7D

-0.7%

1Y

59.6%

Protagonist Therapeutics

Market Cap: US$4.8b

A biopharmaceutical company, develops peptide therapeutics for hematology and blood disorders, and inflammatory and immunomodulatory diseases.

PTGX

US$77.50

7D

-2.1%

1Y

68.6%

KVH Industries

Market Cap: US$108.4m

Engages in the design, development, manufacture, and marketing of mobile connectivity solutions for the marine and land mobile markets in the United States and internationally.

KVHI

US$5.54

7D

-4.2%

1Y

19.7%

Page 1 of 2